Clinical trial · Observational
Vaginal Fluid Collection for Detection of Endometrial Cancer
Vaginal Fluid Collection Study for Endometrial Cancer Test Research and Development
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary objective of this study is to obtain de-identified vaginal fluid specimens from participants with an endometrial tissue biopsy-based histopathological diagnosis of endometrial cancer (EC), endometrial hyperplasia (AEH) with atypia or endometrial intraepithelial neoplasia (EIN). The samples will be used for the purpose of research and development of a new molecular diagnostic test for the detection of EC, AEH and EIN.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Screening test to detect endometrial cancer and precancer | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Detection of endometrial cancer and precancer
- timeFrame
- 4 months
- description
- To provide vaginal fluid specimens to Exact Sciences Corporation to allow for additional research and development of a screening device for the detection of endometrial cancer and endometrial hyperplasia with atypia.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Women ≥18 years of age. 2. Women with endometrial tissue biopsy-based histopathological diagnosis of EC (any histology, including uterine carcinosarcoma), AEH or EIN. 3. Women whose planned surgical intervention (if any) includes hysterectomy, D\&C, or hysteroscopic resection. 4. Participant understands the study procedures and can provide informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigator. \- Exclusion Criteria: 1. Patient with recurrent and/or previously treated EC. 2. Receipt of preoperative neoadjuvant chemotherapy or radiotherapy for current EC diagnosis prior to study enrollment. 3. Prior hysterectomy. 4. Current known pregnancy diagnosis. 5. Prior or current biopsy and histopathology-proven cervical cancer. 6. The presence of concomitant biopsy and histopathology-proven cervical dysplasia. 7. Any prior pelvic or vaginal radiotherapy. 8. Any current or prior cancer diagnosis (except basal cell or squamous cell skin cancer, non-gyn) within the past 5 years. 9. Chemotherapy within the past 5 years. 10. Prior intervention to treat, or surgery with intent to completely remove, the target pathology for the current diagnosis during the current episode.
References
Publications (0)
Data not yet available